BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1618694)

  • 61. [Protocols for lung cancer screening: Limitations, and consequences].
    Clément-Duchêne C; Guillemin F; Paris C; Régent D; Martinet Y
    Rev Mal Respir; 2010 Apr; 27(4):314-28. PubMed ID: 20403542
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcome of patients with lung cancer detected via mass screening as compared to those presenting with symptoms.
    Shimizu N; Ando A; Teramoto S; Moritani Y; Nishii K
    J Surg Oncol; 1992 May; 50(1):7-11. PubMed ID: 1573898
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The early diagnosis of lung cancer.
    Petty TL
    Dis Mon; 2001 Jun; 47(6):204-64. PubMed ID: 11473242
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors.
    McCunney RJ; Li J
    Chest; 2014 Mar; 145(3):618-24. PubMed ID: 24590022
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Hocking WG; Hu P; Oken MM; Winslow SD; Kvale PA; Prorok PC; Ragard LR; Commins J; Lynch DA; Andriole GL; Buys SS; Fouad MN; Fuhrman CR; Isaacs C; Yokochi LA; Riley TL; Pinsky PF; Gohagan JK; Berg CD;
    J Natl Cancer Inst; 2010 May; 102(10):722-31. PubMed ID: 20442215
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does the early detection of lung carcinoma improve prognosis? The Turku Study.
    Salomaa ER
    Cancer; 2000 Dec; 89(11 Suppl):2387-91. PubMed ID: 11147616
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Mayo Lung Project for early detection and localization of bronchogenic carcinoma: a status report.
    Fontana RS; Sanderson DR; Woolner LB; Miller WE; Bernatz PE; Payne WS; Taylor WF
    Chest; 1975 May; 67(5):511-22. PubMed ID: 1126186
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Randomized population trials and screening for lung cancer: breaking the cure barrier.
    Strauss GM
    Cancer; 2000 Dec; 89(11 Suppl):2399-421. PubMed ID: 11147619
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Screening for lung cancer: a review of the current literature.
    Bach PB; Kelley MJ; Tate RC; McCrory DC
    Chest; 2003 Jan; 123(1 Suppl):72S-82S. PubMed ID: 12527566
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diagnosis of lung cancer.
    Selecky PA
    Curr Probl Cancer; 1977 Apr; 1(10):11-21. PubMed ID: 332450
    [No Abstract]   [Full Text] [Related]  

  • 71. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
    Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lung cancer screening has the potential to safe lives, but shall we do it?
    Russi E
    Swiss Med Wkly; 2011; 141():w13185. PubMed ID: 21491209
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up.
    Marcus PM; Bergstralh EJ; Fagerstrom RM; Williams DE; Fontana R; Taylor WF; Prorok PC
    J Natl Cancer Inst; 2000 Aug; 92(16):1308-16. PubMed ID: 10944552
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [A Decrease in Lung Cancer Mortality Following the Implementation of CT Screening for General Population].
    Nawa T
    Igaku Butsuri; 2015; 35(2):158-62. PubMed ID: 26882704
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Lung cancer screening--present status and the problems].
    Naruke T
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2241-6. PubMed ID: 1929444
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography.
    Chien CR; Chen TH
    Int J Cancer; 2008 Jun; 122(11):2594-9. PubMed ID: 18302157
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Population impact of lung cancer screening in the United States: Projections from a microsimulation model.
    Criss SD; Sheehan DF; Palazzo L; Kong CY
    PLoS Med; 2018 Feb; 15(2):e1002506. PubMed ID: 29415013
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Present state and prospectives in the diagnosis and therapy of lung neoplasms. 3. Efficacy of mass screening of lung cancer].
    Yasuda S
    Hokkaido Igaku Zasshi; 1987 Mar; 62(2):200-8. PubMed ID: 3301608
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.